Tafalla, Jenneth S.
HRN: 27-65-78 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/18/2025
CEFUROXIME 500MG (TAB)
10/18/2025
10/24/2025
PO
500mg
BID
NSVD With RMLE
Waiting Final Action